HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Massimo Zollo Selected Research

3',5'-Cyclic-AMP Phosphodiesterases (3',5' Cyclic Nucleotide Phosphodiesterase)

7/2014H-Prune through GSK-3β interaction sustains canonical WNT/β-catenin signaling enhancing cancer progression in NSCLC.
2/2004Prune cAMP phosphodiesterase binds nm23-H1 and promotes cancer metastasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Massimo Zollo Research Topics

Disease

32Neoplasms (Cancer)
04/2021 - 02/2004
14Neoplasm Metastasis (Metastasis)
04/2021 - 02/2004
12Medulloblastoma
01/2020 - 01/2011
8Infections
05/2022 - 01/2011
8Neuroblastoma
01/2018 - 07/2007
8Breast Neoplasms (Breast Cancer)
01/2016 - 01/2005
7COVID-19
01/2022 - 01/2021
3Triple Negative Breast Neoplasms
01/2021 - 01/2013
3Prostatic Neoplasms (Prostate Cancer)
02/2015 - 10/2011
2Carcinogenesis
08/2014 - 08/2012
2Brain Neoplasms (Brain Tumor)
01/2011 - 01/2009
1Virus Diseases (Viral Diseases)
05/2022
1Communicable Diseases (Infectious Diseases)
01/2022
1Polyps
01/2021
1Ependymoma
01/2016
1Cardiovascular Diseases (Cardiovascular Disease)
02/2015
1Chromothripsis
08/2012
1Carcinoma (Carcinomatosis)
04/2011

Drug/Important Bio-Agent (IBA)

20Proteins (Proteins, Gene)FDA Link
02/2022 - 01/2005
6MicroRNAs (MicroRNA)IBA
05/2015 - 01/2009
4CytokinesIBA
01/2022 - 01/2013
4Peptides (Polypeptides)IBA
01/2018 - 01/2013
3Biological ProductsIBA
05/2021 - 12/2010
36-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA
01/2018 - 01/2013
3Tretinoin (Retinoic Acid)FDA LinkGeneric
01/2016 - 07/2007
3CateninsIBA
01/2016 - 01/2012
3Dipyridamole (Persantine)FDA LinkGeneric
01/2013 - 02/2004
2AntibodiesIBA
05/2022 - 01/2021
2Antiviral Agents (Antivirals)IBA
01/2022 - 01/2021
2Serine Proteases (Serine Protease)IBA
01/2022 - 12/2021
2Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
01/2022 - 08/2012
2Angiotensin Receptors (Angiotensin II Receptor)IBA
01/2022 - 12/2021
2Indicators and Reagents (Reagents)IBA
12/2021 - 01/2021
2RNA (Ribonucleic Acid)IBA
12/2021 - 01/2021
2Phosphates (Orthophosphate)IBA
01/2021 - 05/2012
2PolyphosphatesIBA
01/2021 - 07/2014
2CarbohydratesIBA
06/2020 - 05/2012
2Sirtuin 1IBA
01/2018 - 05/2015
2Pharmaceutical PreparationsIBA
03/2017 - 01/2013
2Biomarkers (Surrogate Marker)IBA
01/2016 - 03/2014
23',5'-Cyclic-AMP Phosphodiesterases (3',5' Cyclic Nucleotide Phosphodiesterase)IBA
07/2014 - 02/2004
2Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
11/2012 - 10/2007
1imdevimabIBA
05/2022
1casirivimabIBA
05/2022
1Glycoproteins (Glycoprotein)IBA
05/2022
1AngiotensinsIBA
05/2022
1Monoclonal AntibodiesIBA
05/2022
1Antisense RNA (Anti-Sense RNA)IBA
02/2022
1NF-kappa B (NF-kB)IBA
01/2022
1InterleukinsIBA
01/2022
1Butyrates (Butyrate)IBA
01/2022
1EnzymesIBA
01/2022
1Neuropilin-1IBA
01/2022
1Prothrombin (Factor II)IBA
01/2022
1Complement System Proteins (Complement)IBA
01/2022
1LectinsIBA
01/2022
1NucleoproteinsIBA
12/2021
1S- (2- chloro- 1,1,2- trifluoroethyl)cysteine (CTFC)IBA
05/2021
1Mutant Proteins (Protein, Mutant)IBA
04/2021
1Phosphatidylinositols (Phosphatidylinositol)IBA
04/2021
1Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA
04/2021
1PolymersIBA
01/2021
1Viral Structural Proteins (VP(1))IBA
01/2021
1DNA-Directed RNA Polymerases (RNA Polymerase)IBA
01/2021
1Amino AcidsFDA Link
01/2021
1Angiotensin-Converting Enzyme 2IBA
01/2021
1Viral RNAIBA
01/2021
1Cancer VaccinesIBA
06/2020
1CRM197 (non-toxic variant of diphtheria toxin)IBA
06/2020
1Tn antigenIBA
06/2020
1GlycopeptidesIBA
06/2020
1VaccinesIBA
06/2020
1Caspase 8 (Caspase-8)IBA
01/2018
1histidylhistidine (His-His)IBA
04/2017
1Caspase 9IBA
01/2016
1FenretinideIBA
01/2016
1retinamideIBA
01/2016
1Phosphotransferases (Kinase)IBA
02/2015
1ProteomeIBA
08/2014
1Formaldehyde (Formol)FDA Link
03/2014
1ParaffinIBA
03/2014
1Telomerase (Telomerase Reverse Transcriptase)IBA
12/2013
1pyrimidineIBA
11/2012
1bindaritIBA
08/2012
1AntigensIBA
05/2012
1GuanineIBA
05/2012
1CytosineIBA
05/2012
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
05/2012
1norcantharidinIBA
01/2012
1Cadherins (E-Cadherin)IBA
01/2012
1Cantharidin (Cantharides)IBA
01/2012
1Histidine KinaseIBA
10/2011
1Cell-Free Nucleic AcidsIBA
04/2011
1Therapeutic UsesIBA
01/2011
1LipidsIBA
01/2011

Therapy/Procedure

9Therapeutics
05/2022 - 01/2009
3Drug Therapy (Chemotherapy)
08/2012 - 01/2009
1Cell- and Tissue-Based Therapy (Cell Therapy)
01/2021
1Cytoreduction Surgical Procedures
01/2016
1Radiotherapy
01/2016